Results 61 to 70 of about 83,055,373 (182)

A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation

, 2003
OBJECTIVE: To compare the efficacy of a nitric oxide donor (isosorbide mononitrate) and a prostaglandin E 1 analogue (misoprostol) for cervical priming before suction termination of pregnancy.
Ho, PC, Li, CFI, Chan, CWC
core   +1 more source

A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening: a randomised controlled trial

, 2001
Objective To determine whether a combined therapy with isosorbide mononitrate: (40mg) and misoprostol (400 mug) for pre-operative cervical ripening in the first trimester would result in improved clinical effectiveness, and fewer side effects compared ...
Marie‐Anne Ledingham, Ledingham, MA, Jane E. Norman, Lunan, CB, Andrew J. Thomson, Thomson, AJ, Greer, IA, Norman, JE, C. Burnett Lunan, Ian A. Greer, C Burnett Lunan, Marie-Anne Ledingham, Jane E Norman, Andrew J Thomson, Ian A Greer   +14 more
core   +1 more source

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction

Кардиоваскулярная терапия и профилактика, 2012
Aim. To study the effects of mildronate, as a component of complex therapy, on left ventricular (LV) systolic and diastolic function and exercise capacity (EC) in myocardial infarction (MI) patients undergoing post-hospital rehabilitation.
V. P. Mikhin, O. N. Koltsova
doaj   +1 more source

Isosorbide‐5‐mononitrate [PDF]

Cardiovascular Drug Reviews, 1988
Richard J. Barrett, William R. McConnell, Armen P. Melikian, Wesley C. Pierson, Ulrich W. P. Abshagen   +4 more
openaire   +1 more source

Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices

, 2010
Udgivelsesdato: 2010-OctThe evidence concerning the use of isosorbide-mononitrate (IsMn) for oesophageal varices is ...
E. Langholz, Gluud, Lise Lotte, A. Krag, L. L. Gluud, Krag, Aleksander, Krag, Aleksander Ahm, Langholz, Ebbe   +6 more
core   +1 more source

Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats

, 1991
Rats dosed orally with isosorbide dinitrate (1 mg kg−1) were exposed to smoke from standard and nicotine-reduced cigarettes for 8 min using a smoking machine.
Katsushi Furuno, Yasunori Araki, Yutaka Gomita   +2 more
core   +1 more source

ORGANIC NITRATE CHOICE IN ANTIANGINAL THERAPY OF STABLE ANGINA PECTORIS

Российский кардиологический журнал, 2011
Aim. To assess the use of isosorbide-5-mononitrate in clinical practice and evaluate its benefits in antianginal therapy of stable angina pectoris, based on pharmaco-economic analysis data. Material and methods. The authors analysed 902 medical histories
E. V. Solyanik, E. V. Eliseeva, B. I. Geltser, E. V. Yakukhnaya   +3 more
doaj  

Selective Methylmagnesium Chloride Mediated Acetylations of Isosorbide: A Route to Powerful Nitric Oxide Donor Furoxans

, 2018
Isosorbide was functionalized with furoxan for the first time to give adducts that release nitric oxide up to 7.5 times faster than the commercial vasodilator, isosorbide-5-mononitrate (Is5N).
Richard J. Singer (5146304), Patrick Kielty (5146307), Patrick McArdle (1457956), Peter Cannon (3404489), Michael P. Carty (5146301), Fawaz Aldabbagh (1672639), Michael Kennedy (5146310), Dennis A. Smith (2515480)   +7 more
core   +1 more source

Experiencia clínica con la utilización de nitratos vasodilatadores : Dinitrato de isosorbide y 5-mononitrato de isosorbide en el tratamiento de la insuficiencia cardíaca congestiva en 128 perros [PDF]

, 1995
En este trabajo estudiamos el uso de dos nitratos: dinitrato de isosorbide y su forma activa, el 5-mononitrato de isosorbide, vasodilatadores venosos, en 128 perros con insuficiencia cardíaca: congestiva describiendo su utilización, dosis empleadas ...
Montoya Alonso, A., Martínez Alcaine, M. A., Zec, M., Ynaraja Ramírez, E   +3 more
core   +1 more source

Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease‐Outcomes at 6 Months in the LACI‐2 Randomized Controlled Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Lacunar stroke can cause cognitive decline and dependency. The LACI‐2 (Lacunar Intervention Trial‐2) trial showed that 12 months of treatment with isosorbide‐mononitrate (ISMN) or cilostazol improved these outcomes.
Philip M. Bath, Lisa J. Woodhouse, Iris Mhlanga, John Bamford, Vera Cvoro, Fergus N. Doubal, Timothy J. England, Ahamad Hassan, Alan A. Montgomery, John T. O'Brien, Christine Roffe, Nikola Sprigg, David J. Werring, Joanna M. Wardlaw   +13 more
doaj   +1 more source